Cargando…
The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
Cancer is one of the main causes of disease-related deaths in the world. Although cancer treatment strategies have been improved in recent years, the survival time of cancer patients is still far from satisfied. Cancer immunotherapy, such as Oncolytic virotherapy, Immune checkpoints inhibition, Chim...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801488/ https://www.ncbi.nlm.nih.gov/pubmed/35111663 http://dx.doi.org/10.3389/fonc.2021.704999 |